HCII concentration was higher in moderate and severe cases compared to controls (215 ± 45 μg/ml), but it did not reach statistical significance ( p ≤ 0.05)(Figure 2C ).
← all excerpts
SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity.
1
0.0500
0.0500